š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Study to evaluate the safety and effectiveness of ReFacto AF for the treatm...
Status
Completed
Location
CHU de Nantes
Start Date
2010-02-10
Trial ID
NCT00950170
Treatments Being Tested
To characterize the safety and efficacy of ReFacto AF in treating acute ble...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00037544
Treatments Being Tested
In the present study we are examining the clot formation and clot stability...
Status
Completed
Location
Department of Clinical Biochemistry, Center for Haemophilia and Thrombosis
Start Date
2006-01
Trial ID
NCT00279578
Treatments Being Tested
This NIS aims to assess the patient-reported outcomes (PROs) in enrolled su...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-09-01
Trial ID
NCT02718677
Treatments Being Tested
Moroctocog-alfa (AF-CC) is indicated for the control and prevention of hemo...
Status
Completed
Location
Nirmal Hospital
Start Date
2020-01-25
Trial ID
NCT04396639
Treatments Being Tested
The purpose of this study is to assess the safety, efficacy and pharmacokin...
Status
Unknown
Location
Arkansas Children's Hospital
Start Date
2013-03
Trial ID
NCT01619046
This study is being conducted to compare how moroctocog alfa (AF-CC) acts i...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-08
Trial ID
NCT01579903
Treatments Being Tested
The purpose of this study is to investigate the effectiveness and safety of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
1999-07
Trial ID
NCT00195442
Treatments Being Tested
The study will be investigating pharmacokinetics, safety and efficacy in pa...
Status
Completed
Location
Kuopio University Hospital
Start Date
2009-12
Trial ID
NCT00914459
Treatments Being Tested
To identify the causative mutations in previously untreated patients with h...
Status
Completed
Location
Multiple Locations
Start Date
1994-09
Trial ID
NCT00038909
Treatments Being Tested